APO-LEFLUNOMIDE leflunomide 20mg tablets bottle

Land: Australien

Språk: engelska

Källa: Department of Health (Therapeutic Goods Administration)

Aktiva substanser:

leflunomide, Quantity: 20 mg

Tillgänglig från:

Arrotex Pharmaceuticals Pty Ltd

INN (International namn):

Leflunomide

Läkemedelsform:

Tablet, uncoated

Sammansättning:

Excipient Ingredients: colloidal anhydrous silica; lactose; magnesium stearate; crospovidone

Administreringssätt:

Oral

Enheter i paketet:

30 tablets

Receptbelagda typ:

(S4) Prescription Only Medicine

Terapeutiska indikationer:

Apo-Leflunomide is indicated for the treatment of active rheumatoid arthritis. The combined use of Apo-Leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Produktsammanfattning:

Visual Identification: White, arc-triangular shaped tablet. Engraved "LE" over "20" on one side and "APO" on the other side.; Container Type: Bottle; Container Material: HDPE; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Bemyndigande status:

Licence status A

Tillstånd datum:

2011-07-22